Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Guo

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 12, 2017
[Prognostic value of dynamic monitoring of RUNX1-RUNX1T1 transcript in pediatric acute myeloid leukemia]H T Gao, Y Zhang, K Sun, et al.
The British Journal of Dermatology|April 21, 2005
An insertion-deletion mutation in keratin 9 in three Chinese families with epidermolytic palmoplantar keratodermaX-N Zhang, X-H He, Z Lai, et al.
Journal of Dental Research|October 18, 2018
Chitosan-Based Extrafibrillar Demineralization for Dentin BondingL S Gu, X Cai, J M Guo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 10, 2019
[Prognostic significance of CD56 and CD117 expression in patients with newly diagnosed multiple myeloma treated with bortezomib-based first-line therapy]J Shi, K Sun, Z M Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Comparative study of molecular response of first-line and second-line nilotinib in patients with chronic-phase chronic myelogenous leukemia]H Xu, P Wang, R J Ma, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 6, 2018
[Significance of changed levels of TRACP-5b, PINP and vitamin D3 before and after the treatment of myeloma disease]R J Ma, Z M Zhu, X L Yuan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[The analysis of prognosis-associated factors in adults with acute promyelocytic leukemia]R J Ma, Z M Zhu, X L Yuan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 28, 2017
[Efficacy of combination of ATRA, ATO and anthracyclines induction therapy in patients with acute promyelocytic leukemia]R J Ma, Z M Zhu, X L Yuan, et al.
Yi Chuan Xue Bao = Acta Genetica Sinica|May 2, 2001
[Analyses of chromosomal karyotypes and cytogenetic variations of animal cell lines]D L Zhang, L J Li, G T Xia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 12, 2017
[Prognostic value of dynamic monitoring of RUNX1-RUNX1T1 transcript in pediatric acute myeloid leukemia]H T Gao, Y Zhang, K Sun, et al.
The British Journal of Dermatology|April 21, 2005
An insertion-deletion mutation in keratin 9 in three Chinese families with epidermolytic palmoplantar keratodermaX-N Zhang, X-H He, Z Lai, et al.
Journal of Dental Research|October 18, 2018
Chitosan-Based Extrafibrillar Demineralization for Dentin BondingL S Gu, X Cai, J M Guo, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 10, 2019
[Prognostic significance of CD56 and CD117 expression in patients with newly diagnosed multiple myeloma treated with bortezomib-based first-line therapy]J Shi, K Sun, Z M Zhu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|July 26, 2019
[Comparative study of molecular response of first-line and second-line nilotinib in patients with chronic-phase chronic myelogenous leukemia]H Xu, P Wang, R J Ma, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 6, 2018
[Significance of changed levels of TRACP-5b, PINP and vitamin D3 before and after the treatment of myeloma disease]R J Ma, Z M Zhu, X L Yuan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|August 17, 2017
[The analysis of prognosis-associated factors in adults with acute promyelocytic leukemia]R J Ma, Z M Zhu, X L Yuan, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 28, 2017
[Efficacy of combination of ATRA, ATO and anthracyclines induction therapy in patients with acute promyelocytic leukemia]R J Ma, Z M Zhu, X L Yuan, et al.
Yi Chuan Xue Bao = Acta Genetica Sinica|May 2, 2001
[Analyses of chromosomal karyotypes and cytogenetic variations of animal cell lines]D L Zhang, L J Li, G T Xia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 23, 2023
Toripalimab plus axitinib versus sunitinib as first-line treatment for advanced renal cell carcinoma: RENOTORCH, a randomized, open-label, phase III studyX Q Yan, M J Ye, Q Zou, et al.
Pageof 3